title: Heparan sulfate-dependent and low density lipoprotein receptor-related protein-dependent catabolic pathways for lipoprotein lipase in mouse embryonic fibroblasts.
abstract: Heparan sulfate and low density lipoprotein receptor related protein (LRP) have been shown to participate in the uptake and degradation of the enzyme lipoprotein lipase (LPL). Yet, the contribution of each of these pathways to LPL metabolism and their possible dependence is unknown. In the present study we examined the metabolism of 125I-labeled LPL in untreated and heparinase-treated primary wild-type mouse embryonic fibroblasts (MEF) and in mouse fibroblasts that express single LRP allele (PEA-10) or are lacking the LRP (PEA-13). The degradation of LPL in PEA-13 cells was 30% lower than in MEF and PEA-10 cells. Heparinase treatment decreased the LPL degradation by 58%, 79% and 92%, whereas heparin reduced such degradation by 87%, 90% and 94% in MEF, PEA-10 and PEA-13 cultures, respectively. Assuming that a) heparinase treatment abolished the heparan-sulfate pathway, and that b) the degradation remaining in heparin-treated cultures represents nonspecific values, it appears that heparan sulfate contributes about 61%, 83% and 95% of total LPL degradation, whereas the LRP pathway contributes 39%, 17% and less than 5% of LPL degradation in MEF, PEA-10 and PEA-13 cells, respectively. In addition, the data indicate that LPL interaction with heparan sulfate and the LRP pathways is independent of each other. The study shows that these cells possess both a heparan sulfate-dependent pathway and an LRP-dependent pathway for LPL metabolism and that the two pathways are independent of each other.
authors.affiliation: Institute of Lipid and Atherosclerosis Research, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Sehayek
authors.forename: X X
authors.initials: XX
authors.lastname: Wang
authors.forename: I
authors.initials: I
authors.lastname: Vlodavsky
authors.forename: R
authors.initials: R
authors.lastname: Avner
authors.forename: H
authors.initials: H
authors.lastname: Levkovitz
authors.forename: T
authors.initials: T
authors.lastname: Olivecrona
authors.forename: G
authors.initials: G
authors.lastname: Olivecrona
authors.forename: T E
authors.initials: TE
authors.lastname: Willnow
authors.forename: J
authors.initials: J
authors.lastname: Herz
authors.forename: S
authors.initials: S
authors.lastname: Eisenberg
mesh_terms: D000483:Alleles; D000818:Animals; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D019763:Heparin Lyase; D006497:Heparan Sulfate / Q000378:metabolism*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D051379:Mice; D011133:Polysaccharide-Lyases / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000378:metabolism*; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism*
chemical_list: D006493:Heparin; D019763:Heparin Lyase; D006497:Heparan Sulfate; D008071:Lipoprotein Lipase; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011133:Polysaccharide-Lyases; D011971:Receptors, Immunologic; D011973:Receptors, LDL